Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ENT-01 for Parkinson's Disease Constipation Rollover Study
NCT04483479Phase 2Terminated
- Sponsor
- Enterin Inc.
- Start
- Jul 2020
- Primary completion
- Feb 2022
- Modality
- Multivalent & Scaffold-Based Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of squalamine in Parkinson's disease (PD), constipation, sponsored by Enterin Inc.. Started Jul 2020; status: terminated.
02
Drugs
squalamine
03
Conditions
Parkinson's disease (PD)constipation
Beyond the preview
Go deeper on NCT04483479.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04483479.